SechiEAddisABatzuLet al. Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings. Mult Scler2018; 24: 685–688.
2.
WingerchukDMBanwellBBennettJLet al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology2015; 85: 177–189.
SeokJMChoHJAhnSWet al. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea. Mult Scler2017; 23: 1748–1756.
5.
KimSMWatersPWoodhallMet al. Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G. Mult Scler2017; 23: 1104–1111.
6.
MaoZYinJZhongXet al. Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population. BMC Neurol2015; 15: 160.
7.
CollonguesNMarignierRJacobAet al. Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset. Mult Scler2014; 20: 1086–1094.
8.
CaiGHeDChuLet al. Paraneoplastic neuromyelitis optica spectrum disorders: Three new cases and a review of the literature. The Int J Neurosci2016; 126: 660–668.
